Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Verve Therapeutics, Inc. | Chief Scientific Officer | Common Stock | 1.8K | $11.3K | $6.26 | Jun 21, 2024 | Direct |
Verve Therapeutics, Inc. | Chief Scientific Officer | Stock Option (right to buy) | 32K | Jun 21, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VERV | Verve Therapeutics, Inc. | Jun 21, 2024 | 1 | $0 | 4 | Jun 25, 2024 | Chief Scientific Officer |
VERV | Verve Therapeutics, Inc. | Jun 21, 2024 | 0 | $0 | 3 | Jun 25, 2024 | Chief Scientific Officer |